Filing Details
- Accession Number:
- 0000014272-16-000257
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-01-06 16:40:39
- Reporting Period:
- 2016-01-04
- Filing Date:
- 2016-01-06
- Accepted Time:
- 2016-01-06 16:40:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 14272 | Bristol Myers Squibb Co | BMY | Pharmaceutical Preparations (2834) | 220790350 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1208099 | Lamberto Andreotti | Bristol-Myers Squibb Company 345 Park Avenue New York NY 10154 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.10 Par Value | Disposition | 2016-01-04 | 11,500 | $66.92 | 322,124 | No | 4 | S | Direct | |
| Common Stock, $0.10 Par Value | Disposition | 2016-01-04 | 100 | $67.52 | 322,024 | No | 4 | S | Direct | |
| Common Stock, $0.10 Par Value | Disposition | 2016-01-05 | 11,000 | $68.16 | 311,024 | No | 4 | S | Direct | |
| Common Stock, $0.10 Par Value | Disposition | 2016-01-05 | 600 | $68.78 | 310,424 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock, $0.10 Par Value | 100,000 | Indirect | 2015 Trust |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 27, 2015.
- The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $66.40 to $67.35, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $67.66 to $68.57, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $68.73 to $68.85, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
